Floatz logo

Therapeutic Asset Ratings

9,922 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Mesna
Nervous System Disorder
Indapta Therapeutics, INC.P1CC (43)
Mesna
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
Mesna
Rhabdoid Tumor
St. Jude Children's Research HospitalP1CC (43)
Mesna
Secondary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
Mesna
Wilms Tumor
St. Jude Children's Research HospitalP1CC (43)
Mesothelin-Targeted T Cells
Her2-Receptor Negative Breast Cancer
Memorial Sloan Kettering Cancer CenterP1CC (43)
Metarrestin
Malignant Peripheral Nerve Sheath Tumor
National Cancer Institute (NCI)P1CC (43)
Metformin
Disease Of The Tendon
James WangP1CC (43)
Metformin
Exocrine Pancreatic Carcinoma
City of Hope Medical CenterP1CC (43)
Methotrexate
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Methylphenidate
Brain Hypoxia - Ischemia
Massachusetts General HospitalP1CC (43)
Metoclopramide
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
Mezigdomide
Acute Myeloid Leukemia With Mutated NPM1
Massachusetts General HospitalP1CC (43)
MGC026
Castration-Resistant Prostate Carcinoma
MacroGenicsP1CC (43)
MGC026
Esophageal Squamous Cell Carcinoma
MacroGenicsP1CC (43)
mgc028
Lung Adenocarcinoma
MacroGenicsP1CC (43)
mgd024
CD4+/CD56+ Hematodermic Neoplasm
MacroGenicsP1CC (43)
mgd024
Acute Myeloid Leukemia
MacroGenicsP1CC (43)
mgd024
Lymphoid Leukemia
MacroGenicsP1CC (43)
mgd024
Hairy Cell Leukemia
MacroGenicsP1CC (43)
Mgta-117
Myelodysplastic Syndrome
Magenta Therapeutics, Inc.P1CC (43)
Mib-626
Down Syndrome
Brigham and Women's HospitalP1CC (43)
Miglustat
Glycogen Storage Disease II
Amicus TherapeuticsP1CC (43)
Minnelide
Pancreatic Adenocarcinoma
Minneamrita Therapeutics LLCP1CC (43)
Minocycline
Schizophreniform Disorder
Pakistan Institute of Living and LearningP1CC (43)
Showing 2801 to 2825 of 9,922 assets
PreviousPage 113 of 397Next